Test Price
2,800 AED✅ Home Collection Available
TGFBR2 Gene Genetic Test (Loeys‑Dietz Syndrome Type 2 / Marfanoid Syndromes) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل الجين TGFBR2 لتشخيص متلازمة مارفان ومتلازمة لويز-ديتز في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Trusted Diagnostic Accuracy: 99.9% diagnostic sensitivity for TGFBR2 mutations via ISO 9001:2015 accredited NGS, fully aligned with 2026 DHA genetic testing regulations.
🏥 Premium Home Collection: Complimentary hospital‑grade cold‑chain home sample collection from 8 AM to 11 PM by DHA‑licensed phlebotomists, preserving specimen integrity.
📋 Post‑Test Clinical Guidance: Telephonic result interpretation session with a clinical geneticist to explain findings, inheritance risks, and personalised surveillance plans.
💳 Insurance Verification: Direct billing eligibility check via WhatsApp at +971 54 548 8731. We handle pre‑approvals with all UAE network insurers.
الضمان السريري: حساسية تشخيصية 99.9% لطفرات جين TGFBR2 عبر تقنية التسلسل المتقدم المعتمد من هيئة الصحة بدبي لعام 2026، مع خدمة سحب منزلي معقمة وبإشراف طبي مرخص.
Comprehensive Overview
The TGFBR2 gene test by Next‑Generation Sequencing analyses the entire coding region to diagnose Loeys‑Dietz syndrome type 2 and related Marfanoid conditions. This high‑resolution assay detects single nucleotide variants, small indels, and copy number changes that predispose to aortic aneurysms, arterial tortuosity, and characteristic skin/dermatological features. In the UAE, it is the definitive step for families with thoracic aortic disease and suspected hereditary connective tissue disorders.
تحليل شامل لكامل الجين TGFBR2 للكشف عن الطفرات المسببة لمتلازمة لويز-ديتز من النوع الثاني ومتلازمات تشوهات الأبهر المرتبطة بتورث الأوعية الدموية.
| Feature | Our Test (NGS – UAE Premium) | Closest Alternative (Limited Sanger/Single‑site) |
|---|---|---|
| Analytical Method | Next‑Generation Sequencing (NGS) with copy number analysis | Sanger sequencing or targeted mutation panel |
| Gene Coverage | Full gene: all exons, splice sites, and regulatory regions | Selected exons or known family mutation only |
| Turnaround Time | 3 to 4 weeks | 6 to 8 weeks (multi‑step process) |
| Diagnostic Sensitivity | 99.9% for pathogenic variants (ISO validated) | ~85% depending on region selected |
| UAE Regulatory Compliance | DHA licensed (#9834453), Federal Decree‑Law No. 41 of 2024 compliant | Variable; often unlicensed local referral labs |
| Sample Type | Whole Blood, Extracted DNA, or FTA card (single drop) | Typically blood only |
Physician Insight & Safety Protocol
“As a DHA‑licensed clinical geneticist, I emphasise that a TGFBR2 result, whether positive or negative, must be correlated with your personal and family history. A positive finding does not guarantee a cardiovascular event, but it mandates proactive surveillance and possibly preventive surgery. A negative result does not entirely rule out other genetic causes and careful clinical follow‑up remains essential.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Critical Medication Warning: Do not discontinue any prescribed beta‑blockers, ARBs, or other cardiac medications without consulting your doctor. This genetic test does not replace clinical judgement or current therapy.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent (minors without guardian consent per UAE Child Rights Law [Wadeema’s Law] and CDS Law 2026).
- Exclusion: Active severe infection or acute cardiovascular event; testing should be deferred.
- ER Red Flag: Sudden severe chest or back pain suggestive of aortic dissection – go to the nearest emergency department immediately, do not wait for result.
- ER Red Flag: Sudden loss of vision or stroke‑like symptoms, especially in known TGFBR2 carriers, warrant urgent evaluation.
Patient FAQ & Clinical Guidance
Q1: What exactly does the TGFBR2 gene test detect, and why is it important for UAE residents?
Direct Answer: This NGS detects harmful mutations in the TGFBR2 gene that cause Loeys‑Dietz syndrome type 2, a disorder featuring aortic aneurysms, arterial twists, and distinctive skin and skeletal features often seen in consanguineous families in the UAE.
ما الذي يكشفه فحص الجين TGFBR2؟ يكشف هذا الاختبار الطفرات الممرضة في جين TGFBR2 المسؤولة عن متلازمة لويز-ديتز النوع الثاني والتي تظهر بأعراض تمدد الشريان الأبهر وتشوهات الشرايين ومظاهر جلدية شائعة لدى العائلات ذات زواج الأقارب في الإمارات.
Q2: How is the sample collected, and what do I need to prepare?
Direct Answer: A DHA‑licensed phlebotomist collects either a small blood sample (3‑5 mL) or a single drop on an FTA card during a scheduled home visit, and no fasting or medication changes are required beforehand.
كيف يتم جمع العينة وما التحضير المطلوب؟ يقوم أخصائي سحب معتمد من هيئة الصحة بدبي بجمع عينة دم بسيطة (3-5 مل) أو قطرة على بطاقة FTA خلال زيارة منزلية، ولا تحتاج إلى صيام أو تغيير أدويتك.
Q3: How long do results take, and who will explain them to me?
Direct Answer: You will receive a comprehensive report within 3 to 4 weeks, followed by a telephonic genetic counselling session where a clinical geneticist interprets the meaning of your result, discusses family implications, and advises on cardiovascular surveillance.
كم مدة النتائج ومن سيشرحها؟ تحصل على التقرير الشامل خلال 3 إلى 4 أسابيع تعقبها جلسة استشارة وراثية هاتفية يفسر فيها أخصائي الوراثة السريرية النتائج ويشرح تأثيرها العائلي وخطة المراقبة القلبية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians